Prodrugs for improving tumor targetability and efficiency.
about
Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and ChallengesProstate cancer relevant antigens and enzymes for targeted drug deliveryStrategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and marketProgress and problems with the use of suicide genes for targeted cancer therapyProdrug applications for targeted cancer therapy.Prodrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380Promotion of initial anti-tumor effect via polydopamine modified doxorubicin-loaded electrospun fibrous membranes.Aromatic aldehyde and hydrazine activated peptide coated quantum dots for easy bioconjugation and live cell imagingOrganic carbamates in drug design and medicinal chemistryLipophilic prodrug conjugates allow facile and rapid synthesis of high-loading capacity liposomes without the need for post-assembly purification.Protease-activated drug development.Preparation, characterization, and in vitro drug release behavior of glutathione-sensitive long-circulation micelles based on polyethylene glycol prodrug.Polyactives: controlled and sustained bioactive release via hydrolytic degradation.Enhanced Cellular Uptake and Pharmacokinetic Characteristics of Doxorubicin-Valine Amide Prodrug.One-component nanomedicineA facile route to form self-carried redox-responsive vorinostat nanodrug for effective solid tumor therapyN-Heterocyclic Carbene-Gold(I) Complexes Conjugated to a Leukemia-Specific DNA Aptamer for Targeted Drug DeliverySynthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.Novel nanoparticulate systems for lung cancer therapy: an updated review.A pH-responsive carboxymethyl dextran-based conjugate as a carrier of docetaxel for cancer therapy.A peptide-based pH-sensitive drug delivery system for targeted ablation of cancer cells.Development of sulfadiazine-decorated PLGA nanoparticles loaded with 5-fluorouracil and cell viability.Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16.CYP3A4-dependent cellular response does not relate to CYP3A4-catalysed metabolites of C-1748 and C-1305 acridine antitumor agents in HepG2 cells.Antitumor activity of an enzyme prodrug therapy targeted to the breast tumor vasculature.RAFT-derived polymer-drug conjugates: poly(hydroxypropyl methacrylamide) (HPMA)-7-ethyl-10-hydroxycamptothecin (SN-38) conjugates.Prodrug enzymes and their applications in image-guided therapy of cancer: tracking prodrug enzymes to minimize collateral damage.Circumvention of P-gp and MRP2 mediated efflux of lopinavir by a histidine based dipeptide prodrug.Stimuli-responsive multifunctional glyconanoparticle platforms for targeted drug delivery and cancer cell imagingMultivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin αV β3.ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy.Design of Block Copolymer Micellar Aggregates for Co-Delivery of Enzyme and Anticancer Prodrug.Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy.Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy.Dual turn-on fluorescence signal-based controlled release system for real-time monitoring of drug release dynamics in living cells and tumor tissues.A redox-responsive mesoporous silica based nanoplatform for in vitro tumor-specific fluorescence imaging and enhanced photodynamic therapy.Three-Arm, Biotin-Tagged Carbazole-Dicyanovinyl-Chlorambucil Conjugate: Simultaneous Tumor Targeting, Sensing, and Photoresponsive Anticancer Drug Delivery.pH-sensitive pHluorins as a molecular sensor for in situ monitoring of enzyme-catalyzed prodrug activation.Delivering aminopyridine ligands into cancer cells through conjugation to the cell-penetrating peptide BP16.Biotin-conjugated tumour-targeting photocytotoxic iron(III) complexes.
P2860
Q26798105-DDD2F5AB-2657-4252-87B1-0E4F4A72EB6CQ27013843-779638C6-04F7-4E1A-9778-4A8E15D47CA0Q27015050-0EA35657-7873-4F89-8669-AA49E64AC0E9Q28262370-E2F9218D-A7B5-48C8-A94F-12D51086F12CQ34099780-CAB5BB25-0461-48E0-8142-585DBB1B8E73Q34231935-F7BE18EE-BF00-4B7D-A793-B68DA2711E76Q34371109-FFE50BF0-4313-4224-B43F-FA7594DE8DCDQ35048284-5559400E-E14E-41A8-B189-C680E25D0878Q35365543-0A4D7187-2158-479D-B2EB-53486D6DBD60Q35773072-D3D3BF44-D1DF-4E0F-8A0A-5B483034D0A7Q35811508-788E6D4C-251D-484B-A607-C6DDF63DB587Q35893655-4CC447DA-D84A-444C-BE6A-AEEA9A6BE3FDQ35902758-FE207C52-E624-4918-B0CF-7FBBCE0EF09EQ36144978-BE3A9619-1CCF-444E-88D0-FB8C2E27E436Q36307689-9B00A01C-BBE0-4ACF-9519-71F3AD189379Q37420756-37257EA0-629D-46E7-8989-5A44B5A0394CQ37603242-A6B42257-EECA-4652-840A-B75270DD9F72Q37706245-336AF06F-B37E-427C-AF7E-099B31D83820Q38762917-2890D1A2-C6FE-4A48-838D-D5EF605B27DCQ38810269-FFC724FB-6EB7-4A45-B898-FD48BA49C587Q38843320-92790A34-07AA-42EE-974C-4ADAF3DF68A5Q38920845-C02001DC-0DEC-4852-AF22-3A0E2DB80843Q38932275-A5986E99-5FC7-4137-84E4-30317C0A77BDQ38988914-8068636F-2958-4619-9280-FF1E4AB366B5Q39089294-F5A31CE4-43E0-4145-A62B-7471C2DE1377Q39432578-AB8842CC-A8EC-4A1F-8654-1A1E64E8FF06Q40262447-9244401C-7F31-4DE2-898F-2834BCF309A4Q40569235-421D4609-9BC1-4DDF-A8EF-324FF038AAB8Q42263510-DA95E60C-CA23-4ADA-9B1C-6F10F4B3BA87Q42801541-BD8514EA-C718-45B8-ACD7-090DB61361FAQ43264652-E1170438-F301-4014-B583-4DFCCB6559CDQ46446276-D4C08BA0-95D5-44CD-9E9F-301553036458Q47621457-25E84573-740A-4248-B73E-DFC4AE1584ADQ47712185-2E82C50F-D572-4F0C-A70B-C1932846BEC8Q49165407-BCDC8B7A-ED8F-45DE-9795-959823C0DBC1Q49550978-7AC10425-8935-452C-B98A-BCE49018776EQ50196756-7E46A45B-454C-4024-B62F-5406F29C89E6Q50227405-D0427244-5FD4-449A-8E0C-32D94BAEC47EQ50857768-2E952C98-FF45-4F6F-AE62-7DD49CD649B7Q51199383-1E5F43B3-91FA-4A6D-A08D-020EE8E371BB
P2860
Prodrugs for improving tumor targetability and efficiency.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prodrugs for improving tumor targetability and efficiency.
@ast
Prodrugs for improving tumor targetability and efficiency.
@en
type
label
Prodrugs for improving tumor targetability and efficiency.
@ast
Prodrugs for improving tumor targetability and efficiency.
@en
prefLabel
Prodrugs for improving tumor targetability and efficiency.
@ast
Prodrugs for improving tumor targetability and efficiency.
@en
P2860
P1476
Prodrugs for improving tumor targetability and efficiency
@en
P2093
Rubi Mahato
P2860
P304
P356
10.1016/J.ADDR.2011.02.002
P407
P50
P577
2011-02-17T00:00:00Z